Submit Separate Retrospective, Prospective Study data of subjects: CDSCO Panel Tells Takeda on Velaglucerase alfa study Dr. Divya Colin15 July 2024 6:00 PM ISTNew Delhi: Regarding the post-marketing surveillance study of the drug major Takeda Pharmaceutical's Velaglucerase alfa injection, the Subject Expert...
Takeda gets European Commission approval for Fruzaqla for previously treated metastatic Colorectal cancer Ruchika Sharma23 Jun 2024 12:00 PM ISTFRUZAQLA is a selective oral inhibitor of all three VEGF receptors (-1, -2 and -3). VEGFR inhibitors play a pivotal role in blocking tumor...
Takeda announces Phase 3 topline results for Soticlestat in patients with Dravet Syndrome, Lennox-Gastaut Syndrome Ruchika Sharma18 Jun 2024 4:14 PM ISTOsaka: Takeda has announced topline data from its SKYLINE and SKYWAY studies. SKYLINE (TAK-935-3001) was a multicenter, randomized, double-blind...
Takeda signs option agreement with Ascentage Pharma to enter into exclusive global license for Olverembatinib Ruchika Sharma16 Jun 2024 10:30 AM ISTJapan: Takeda has announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for...
Takeda Biopharma names Annapurna Das as General Manager for India Operations Ruchika Sharma17 May 2024 11:36 AM ISTMumbai: Takeda Biopharmaceuticals India Pvt Ltd (formerly known as Baxalta Bioscience India Private Limited), part of a global values-based,...
India becoming attractive for clinical trials: Pharma industry leaders Ruchika Sharma29 April 2024 2:33 PM ISTNew Delhi: Experts from the pharmaceutical sector have noted that over the last decade, clinical trials in India have undergone significant...
Takeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease Ruchika Sharma21 April 2024 10:00 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC)...
Takeda bags accelerated USFDA nod for Iclusig with chemotherapy in adult patients with newly diagnosed Ph+ ALL Ruchika Sharma22 March 2024 11:57 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for...
Biological E, Takeda join hands to accelerate access to Dengue Vaccine in endemic areas Ruchika Sharma29 Feb 2024 3:00 PM ISTHyderabad: Takeda and Biological E. Limited (BE), an India-based Vaccines and Pharmaceutical Company, has announced a strategic partnership...
FDA approves budesonide oral suspension for treatment of eosinophilic esophagitis Dr. Kamal Kant Kohli14 Feb 2024 10:00 AM ISTThe Food and Drug Administration (FDA) has approved EOHILIA (budesonide) oral suspension for treatment of eosinophilic esophagitis among adults and...
Takeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis Ruchika Sharma13 Feb 2024 1:30 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and...
Takeda Hyqvia gets USFDA nod for Chronic Inflammatory Demyelinating Polyneuropathy Ruchika Sharma17 Jan 2024 3:54 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved HYQVIA [Immune Globulin Infusion 10% (Human) with...
